Moneycontrol PRO
HomeNewsAjantapharma

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Short Ajanta Pharma, says Shrikant Chouhan

    Short Ajanta Pharma, says Shrikant Chouhan, VP Technical Research of Kotak Securities.

  • Super Six stocks you can bet on Oct 3

    Super Six stocks you can bet on Oct 3

    On CNBC-TV18's in Super Six show, market gurus Hemen Kapadia, CEO of chartpundit.com, Shrikant Chouhan, VP Technical Research of Kotak Securities and Sanjeev Agarwal, CEO of Dynamix Research & Capital Management, place their bets on two stocks each, thus offering investors a variety of options to choose from.

  • Buy Ajanta Pharma with stoploss of Rs 325: Agarwal

    Buy Ajanta Pharma with stoploss of Rs 325: Agarwal

    Buy Ajanta Pharma with a stoploss of Rs 325, says Rajesh Agarwal, Head of Research at Eastern Financiers.

  • Bull's Eye: 12 trading bets to boost your portfolio

    Bull's Eye: 12 trading bets to boost your portfolio

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Ajanta Pharma has target of Rs 320: Rajesh Jain

    Ajanta Pharma has target of Rs 320: Rajesh Jain

    Ajanta Pharma has target of Rs 320, says Rajesh Jain, Market Strategist

  • Bull's Eye: 12 trading ideas for good return

    Bull's Eye: 12 trading ideas for good return

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest. Remember these are midcap ideas not just for the day, but stocks that look attractive in the medium-term as well.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347